Health Catalyst (NASDAQ: HCAT) insider sells 18,270 restricted shares reported

Rhea-AI Filing Summary

Health Catalyst, Inc. insider selling activity reported: Benjamin Albert disclosed dispositions of restricted Common shares and a planned resale. The filing lists dispositions of 13,304 restricted shares on 02/26/2026 and 4,966 restricted shares on 03/02/2026, totaling 18,270 shares reported in the past three months. The filing also shows a listed resale entry dated 03/10/2026 for restricted Common stock tied to compensation.

Insights

Corporate Governance Analyst

Insider disclosed recent restricted-share dispositions totaling 18,270 shares.

The filing shows two disclosed dispositions by Benjamin Albert: 13,304 shares on 02/26/2026 and 4,966 shares on 03/02/2026. These are recorded as restricted stock dispositions tied to compensation.

Timing and cash‑flow treatment are not detailed in the excerpt; subsequent filings or broker reports would show whether sales were market transactions or tax withholdings.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	70455	130207.89	70730884	03/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/10/2026	Restricted Stock	Health Catalyst, Inc.			70455	03/10/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Benjamin Albert c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	02/26/2026	13304	23252.73
Benjamin Albert c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	03/02/2026	4966	8243.06

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What share dispositions did Benjamin Albert report in the HCAT Form 144?

He reported dispositions of 13,304 restricted shares on 02/26/2026 and 4,966 restricted shares on 03/02/2026. The form totals 18,270 shares reported over the past three months and lists a resale entry dated 03/10/2026.

Does the Form 144 show why the shares were sold for HCAT?

The filing classifies the securities as Restricted Stock and ties them to Compensation. It does not provide additional reasons or detailed cash‑flow treatment in the provided excerpt; the entries list transaction dates and share counts only.

What date is listed for the resale entry in the HCAT excerpt?

The resale entry in the excerpt is dated 03/10/2026 and references Common restricted stock. That entry is linked to compensation-related restricted shares, per the filing lines shown in the excerpt.

How many total restricted shares are shown as sold in the past three months?

The excerpt shows a total of 18,270 restricted shares sold in the past three months, combining 13,304 on 02/26/2026 and 4,966 on 03/02/2026. Values for each sale are also listed in the excerpt.

Are transaction values disclosed for the HCAT dispositions?

Yes. The excerpt lists monetary amounts: $23,252.73 associated with the 13,304-share entry and $8,243.06 with the 4,966-share entry, as shown on the filing lines provided.